[Congressional Record (Bound Edition), Volume 160 (2014), Part 13]
[Senate]
[Page 17771]
[From the U.S. Government Publishing Office, www.gpo.gov]


          UNITED STATES ANTI-DOPING AGENCY REAUTHORIZATION ACT

  Mr. PRYOR. Madam President, I ask unanimous consent that the Senate 
proceed to the immediate consideration of Calendar No. 608, S. 2338.
  The PRESIDING OFFICER. The clerk will report the bill by title.
  The assistant legislative clerk read as follows:

       A bill (S. 2338) to reauthorize the United States Anti-
     Doping Agency, and for other purposes.

  There being no objection, the Senate proceeded to consider the bill.
  Mr. PRYOR. I ask unanimous consent that the bill be read a third time 
and passed and the motion to reconsider be considered made and laid 
upon the table.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The bill (S. 2338) was ordered to be engrossed for a third reading, 
was read the third time, and passed, as follows:

                                S. 2338

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``United States Anti-Doping 
     Agency Reauthorization Act''.

     SEC. 2. PROHIBIT PERFORMANCE-ENHANCING METHODS.

       Section 701 of title VII of the Office of National Drug 
     Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001) 
     is amended--
       (1) in subsection (a), by striking paragraph (4); and
       (2) in subsection (b)--
       (A) in paragraph (1), by inserting ``and be recognized 
     worldwide as the independent national anti-doping 
     organization for the United States'' after ``Committee'';
       (B) in paragraph (2), by striking ``, or performance-
     enhancing genetic modifications accomplished through gene-
     doping'' and inserting ``or prohibited performance-enhancing 
     methods adopted by the Agency'';
       (C) in paragraph (3), by striking ``, or performance-
     enhancing genetic modifications accomplished through gene-
     doping'' and inserting ``or prohibited performance-enhancing 
     methods adopted by the Agency'';
       (D) in paragraph (4), by striking ``and the prevention of 
     use of performance-enhancing drugs, or performance-enhancing 
     genetic modifications accomplished through gene-doping by 
     United States amateur athletes; and'' and inserting ``, and 
     the prevention of use by United States amateur athletes of 
     performance-enhancing drugs or prohibited performance-
     enhancing methods adopted by the Agency.''; and
       (E) by striking paragraph (5).

     SEC. 3. AUTHORIZATION OF APPROPRIATIONS.

       Section 703 of title VII of the Office of National Drug 
     Control Policy Reauthorization Act of 2006 (21 U.S.C. 2003) 
     is amended to read as follows:

     ``SEC. 703. AUTHORIZATION OF APPROPRIATIONS.

       ``There are authorized to be appropriated to the United 
     States Anti-Doping Agency--
       ``(1) for fiscal year 2014, $11,300,000;
       ``(2) for fiscal year 2015, $11,700,000;
       ``(3) for fiscal year 2016, $12,300,000;
       ``(4) for fiscal year 2017, $12,900,000;
       ``(5) for fiscal year 2018, $13,500,000;
       ``(6) for fiscal year 2019, $14,100,000; and
       ``(7) for fiscal year 2020, $14,800,000.''.

     

                          ____________________